<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>ANI Pharmaceuticals Inc. (ANIP) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/anip/</link>
<description>Every dated entry in the public record on ANI Pharmaceuticals Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/anip/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Mon, 12 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>ANI Pharmaceuticals Inc.: Carey Stephen P. (SVP &amp; CFO) sold 2,850 shares at $73.00 on 29 September 2026, $208,050</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-09-30:7cc575732f</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000167423626000024/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: short interest 3,491,281 shares at the 30 September 2026 settlement, 7.16 days to cover</title><link>https://greeksoup.ai/stocks/us/anip/short-interest/</link><guid isPermaLink="false">us:ANIP:short-interest:2026-09-30:2fd0c08239</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Lalwani Nikhil (PRESIDENT &amp; CEO) sold 5,400 shares at $71.00 on 15 September 2026, $383,400</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-09-16:b612e931c3</guid><pubDate>Wed, 16 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000182262926000016/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Form 144, NIKHIL LALWANI plans to sell 5,400 shares worth $380,160 around 15 September 2026</title><link>https://greeksoup.ai/stocks/us/anip/planned-sales/</link><guid isPermaLink="false">us:ANIP:planned-sale:2026-09-15:3bfe6150b8</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000195004726009487/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: short interest 2,490,166 shares at the 15 September 2026 settlement, 7.44 days to cover</title><link>https://greeksoup.ai/stocks/us/anip/short-interest/</link><guid isPermaLink="false">us:ANIP:short-interest:2026-09-15:41d3d33d7e</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Cook Meredith (SR. VP, GENERAL COUNSEL &amp; SEC.) sold 500 shares at $70.79 on 14 September 2026, $35,395</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-09-14:29b85e0026</guid><pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000193886126000026/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Thoma Jeanne (Director) sold 1,000 shares at $71.53 on 11 September 2026, $71,530</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-09-14:4426b27c86</guid><pubDate>Mon, 14 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000181987926000006/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Form 144, JEANNE THOMA plans to sell 1,000 shares worth $71,460 around 11 September 2026</title><link>https://greeksoup.ai/stocks/us/anip/planned-sales/</link><guid isPermaLink="false">us:ANIP:planned-sale:2026-09-11:06b57169f3</guid><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000195004726009361/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Carey Stephen P. (SVP &amp; CFO) sold 2,850 shares at $72.80 on 31 August 2026, $207,480</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-09-01:154a7ca39e</guid><pubDate>Tue, 01 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000167423626000022/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: short interest 3,364,919 shares at the 31 August 2026 settlement, 9.22 days to cover</title><link>https://greeksoup.ai/stocks/us/anip/short-interest/</link><guid isPermaLink="false">us:ANIP:short-interest:2026-08-31:9082e4adcd</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Lalwani Nikhil (PRESIDENT &amp; CEO) sold 5,400 shares at $74.30 on 25 August 2026, $401,220</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-08-26:a220fe5416</guid><pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000182262926000014/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Form 144, NIKHIL LALWANI plans to sell 5,400 shares worth $400,518 around 25 August 2026</title><link>https://greeksoup.ai/stocks/us/anip/planned-sales/</link><guid isPermaLink="false">us:ANIP:planned-sale:2026-08-25:9b831d159b</guid><pubDate>Tue, 25 Aug 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000195004726008689/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc. filed 8-K: officer or director change</title><link>https://greeksoup.ai/stocks/us/anip/filings/</link><guid isPermaLink="false">us:ANIP:filing:2026-08-24:881623eca7</guid><pubDate>Mon, 24 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000102302426000071/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: short interest 3,420,781 shares at the 14 August 2026 settlement, 7.37 days to cover</title><link>https://greeksoup.ai/stocks/us/anip/short-interest/</link><guid isPermaLink="false">us:ANIP:short-interest:2026-08-14:9fd624f0d7</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Cook Meredith (SR. VP, GENERAL COUNSEL &amp; SEC.) sold 500 shares at $75.48 on 13 August 2026, $37,740</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-08-13:63ed9ef780</guid><pubDate>Thu, 13 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000193886126000023/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Gutwerg Ori (SVP, GENERICS) sold 3,162 shares at $77.00 on 10 August 2026, $243,474</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-08-11:4336a166f1</guid><pubDate>Tue, 11 Aug 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000184647826000015/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc. Q2 FY2026 results: revenue $266 million, net income $25 million</title><link>https://greeksoup.ai/stocks/us/anip/results/fy2026-q2/</link><guid isPermaLink="false">us:ANIP:result:2026-08-07:9c1fd1d509</guid><pubDate>Fri, 07 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001023024&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/anip/filings/</link><guid isPermaLink="false">us:ANIP:filing:2026-08-07:bc36563784</guid><pubDate>Fri, 07 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000102302426000069/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc. filed 8-K: results of operations, regulation fd disclosure</title><link>https://greeksoup.ai/stocks/us/anip/filings/</link><guid isPermaLink="false">us:ANIP:filing:2026-08-07:70f08ee801</guid><pubDate>Fri, 07 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000102302426000068/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: short interest 2,334,112 shares at the 31 July 2026 settlement, 9.25 days to cover</title><link>https://greeksoup.ai/stocks/us/anip/short-interest/</link><guid isPermaLink="false">us:ANIP:short-interest:2026-07-31:7a15a05ead</guid><pubDate>Fri, 31 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Carey Stephen P. (SVP &amp; CFO) sold 2,850 shares at $81.36 on 29 July 2026, $231,876</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-07-30:c0c220fab5</guid><pubDate>Thu, 30 Jul 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000167423626000019/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Form 144, STEPHEN P CAREY plans to sell 6,163 shares worth $499,450 around 29 July 2026</title><link>https://greeksoup.ai/stocks/us/anip/planned-sales/</link><guid isPermaLink="false">us:ANIP:planned-sale:2026-07-29:be677c1d8b</guid><pubDate>Wed, 29 Jul 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000195004726007411/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Schedule 13G/A filed by BlackRock, Inc., 12.8% of the class</title><link>https://greeksoup.ai/stocks/us/anip/holders/</link><guid isPermaLink="false">us:ANIP:schedule-13:2026-07-27:d40fc75876</guid><pubDate>Mon, 27 Jul 2026 00:00:00 +0000</pubDate><category>Schedule 13D/13G</category><description><![CDATA[<p>Schedule 13D/13G. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000201238326002156/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/holders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc. filed S-8: s-8</title><link>https://greeksoup.ai/stocks/us/anip/filings/</link><guid isPermaLink="false">us:ANIP:filing:2026-07-17:af460e2b04</guid><pubDate>Fri, 17 Jul 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000102302426000059/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: short interest 3,371,249 shares at the 15 July 2026 settlement, 10.97 days to cover</title><link>https://greeksoup.ai/stocks/us/anip/short-interest/</link><guid isPermaLink="false">us:ANIP:short-interest:2026-07-15:200f6d9fba</guid><pubDate>Wed, 15 Jul 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>ANI Pharmaceuticals Inc.: Cook Meredith (SR. VP, GENERAL COUNSEL &amp; SEC.) sold 500 shares at $81.84 on 13 July 2026, $40,920</title><link>https://greeksoup.ai/stocks/us/anip/insiders/</link><guid isPermaLink="false">us:ANIP:insider:2026-07-14:02ac9c4e20</guid><pubDate>Tue, 14 Jul 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/1023024/000193886126000019/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/anip/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
